Saturday, 19 April 2014
Gilead steps into breach left by AbbVie as Galapagos' partner
Gilead Sciences has earmarked $2bn to take a stake in Belgium's Galapagos and buy into its filgotinib drug candidate for rheumatoid arthritis.
Saturday, 19 April 2014
Merck finally bags FDA approval for Bridion
The US FDA has approved Merck & Co's Bridion to reverse the effects of neuromuscular blockade induced by muscle relaxants used during surgery.
Copyright 2016 Green Nature. All rights reserved